This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: University of Aberdeen, Wista Laboratories Ltd.. Active years: 2002-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2012
Title: Martin Roth - Innovator in Alzheimer's Disease Research
Introduction
Martin Roth is a distinguished inventor based in Cambridge, GB. He has made significant contributions to the field of neurodegenerative diseases, particularly in the context of Alzheimer's disease. With a total of 4 patents to his name, Roth's work focuses on innovative therapeutic approaches to combat these debilitating conditions.
Latest Patents
Roth's latest patents include groundbreaking inventions aimed at inhibiting tau-tau association, which is crucial in the pathology of Alzheimer's disease and other related disorders. One of his notable patents describes a composition and its use for the prophylaxis or treatment of Alzheimer's disease, motor neurone disease, Lewy body disease, Pick's disease, or progressive supranuclear palsy. This composition includes an agent that modulates or inhibits tau-tau association without affecting tau-tubulin binding. The method involves administering this agent, preferably a phenothiazine compound, to achieve the desired therapeutic effect. Another patent focuses on methods for detecting substances that can modulate or inhibit pathological tau-tau protein association, which is particularly useful in screening for potential treatments for Alzheimer's disease.
Career Highlights
Throughout his career, Martin Roth has worked with reputable institutions, including the University of Aberdeen and Wista Laboratories Ltd. His research has significantly advanced the understanding of tau protein's role in neurodegenerative diseases, paving the way for new therapeutic strategies.
Collaborations
Roth has collaborated with notable colleagues in his field, including Claude Michel Wischik and Patricia Carol Edwards. These partnerships have further enriched his research and contributed to the development of innovative solutions for Alzheimer's disease.
Conclusion
Martin Roth's contributions to the field of neurodegenerative disease research are invaluable. His innovative patents and collaborations highlight his commitment to finding effective treatments for Alzheimer's disease and related disorders. His work continues to inspire advancements in medical research and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile